Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Avita Medical Ltd buy krebskrebs

Start price
€2.00
10.01.22 / 50%
Target price
€3.00
10.01.23
Performance (%)
-29.75%
End price
€1.41
11.01.23
Summary
This prediction ended on 11.01.23 with a price of €1.41. The prediction for Avita Medical Ltd disappointed with a performance of -29.75%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Avita Medical Ltd 3.659% 3.659% -40.559%
iShares Core DAX® 2.831% 1.236% 14.788%
iShares Nasdaq 100 2.918% 0.640% 40.290%
iShares Nikkei 225® 2.007% -2.135% 19.861%
iShares S&P 500 2.257% 0.451% 30.090%

Comments by krebskrebs for this prediction

In the thread Avita Medical Ltd diskutieren
Prediction Buy
Perf. (%) -29.75%
Target price 3.000
Change
Ends at

Buy mit Kursziel 3,0

In the thread Trading Avita Medical Ltd
Prediction Buy
Perf. (%) -29.75%
Target price 3.000
Change
Ends at 10.01.23

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten